Lee Swem
Keine laufenden Positionen mehr
Profil
Lee Swem formerly worked at Achaogen, Inc., as Chief Scientific Officer from 2017 to 2018.
Dr. Swem received his doctorate degree from Indiana University.
Ehemalige bekannte Positionen von Lee Swem
| Unternehmen | Position | Ende |
|---|---|---|
| ACHAOGEN | Technik-/Wissenschafts-/F&E-Leiter | 24.09.2018 |
Ausbildung von Lee Swem
| Indiana University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
